Jin He

1.3k total citations
47 papers, 907 citations indexed

About

Jin He is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jin He has authored 47 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Jin He's work include Glioma Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jin He is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jin He collaborates with scholars based in China, Sweden and United States. Jin He's co-authors include Huimin Liu, Weiqing Li, Yicheng Lu, Yiming Li, Guohan Hu, Hongyu Yu, Yongji Yang, Cheng He, Juxiang Chen and Hongyu Yu and has published in prestigious journals such as Oncogene, Scientific Reports and Brain Research.

In The Last Decade

Jin He

44 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin He China 16 570 356 167 110 98 47 907
Yangfan Lv China 16 583 1.0× 359 1.0× 205 1.2× 86 0.8× 130 1.3× 31 892
Liangcai Wu China 15 277 0.5× 200 0.6× 166 1.0× 80 0.7× 128 1.3× 24 635
Linni Fan China 16 319 0.6× 186 0.5× 151 0.9× 128 1.2× 93 0.9× 50 649
Zhanjun Guo China 21 903 1.6× 433 1.2× 180 1.1× 42 0.4× 123 1.3× 94 1.3k
Jeanie Wu Singapore 13 552 1.0× 258 0.7× 218 1.3× 108 1.0× 149 1.5× 14 904
Péter Tátrai Hungary 21 459 0.8× 157 0.4× 214 1.3× 59 0.5× 106 1.1× 37 956
Jingwang Bi China 18 619 1.1× 334 0.9× 321 1.9× 80 0.7× 220 2.2× 27 989
Limin Zhai China 16 448 0.8× 350 1.0× 140 0.8× 77 0.7× 53 0.5× 33 763
Nam-Gyun Kim South Korea 9 428 0.8× 305 0.9× 157 0.9× 122 1.1× 151 1.5× 11 854
Feng Tang China 16 436 0.8× 235 0.7× 314 1.9× 104 0.9× 121 1.2× 34 849

Countries citing papers authored by Jin He

Since Specialization
Citations

This map shows the geographic impact of Jin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin He more than expected).

Fields of papers citing papers by Jin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin He. The network helps show where Jin He may publish in the future.

Co-authorship network of co-authors of Jin He

This figure shows the co-authorship network connecting the top 25 collaborators of Jin He. A scholar is included among the top collaborators of Jin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin He. Jin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingfu, et al.. (2025). Hydrogel-Based Vaccines: A Promising Approach for Cancer Immunotherapy. International Journal of Nanomedicine. Volume 20. 11389–11415.
2.
He, Jin, Yawen Liu, Jing Yu, et al.. (2025). Design, synthesis, and biological evaluation of novel artemisinin-based HDAC inhibitors with antitumor and antimalarial activities. Bioorganic Chemistry. 157. 108312–108312. 1 indexed citations
3.
Wang, Zhen, et al.. (2024). Investigation of the pathogenesis of ADAR1 gene in dyschromatosis symmetrica hereditaria. Experimental Dermatology. 33(2). e15031–e15031. 2 indexed citations
4.
Wang, Xueting, Hui Zhang, Ling Hu, et al.. (2024). The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation. Bone. 187. 117172–117172.
5.
He, Jin, et al.. (2024). The relationship between adolescents’ physical activity, circadian rhythms, and sleep. Frontiers in Psychiatry. 15. 1415985–1415985. 2 indexed citations
6.
Wang, Wei, Lijia Yao, Weifeng Shen, et al.. (2017). FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice. Scientific Reports. 7(1). 15532–15532. 37 indexed citations
7.
He, Jin, et al.. (2015). Chinese Tea Ceremony. 21(2). 12–15. 1 indexed citations
8.
Ma, Xiaomei, et al.. (2015). Pilomyxoid astrocytomas with rare rosenthal fibers. Brain Tumor Pathology. 33(1). 35–39. 2 indexed citations
9.
Li, Weiqing, Hongyu Yu, Yiming Li, et al.. (2014). Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor. Biochemical and Biophysical Research Communications. 446(4). 1261–1267. 11 indexed citations
10.
Ma, Xiaomei, et al.. (2013). Pigmented villonodular synovitis: a retrospective study of seventy five cases (eighty one joints). International Orthopaedics. 37(6). 1165–1170. 41 indexed citations
11.
Zhao, Liming, Lei Jiang, Jin He, et al.. (2012). UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 138(11). 1951–1961. 15 indexed citations
12.
Li, Weiqing, Chao Chen, Midie Xu, et al.. (2011). The rno‐miR‐34 family is upregulated and targets ACSL1 in dimethylnitrosamine‐induced hepatic fibrosis in rats. FEBS Journal. 278(9). 1522–1532. 97 indexed citations
13.
Wang, Qiang, Lieying Fan, Jin He, & Yuanhe Wang. (2011). Inhibitory effect of sulindac against chemically-induced primary colonic tumors by N-methyl-N-nitrosourea in mice. World Journal of Gastroenterology. 3(1). 16–16.
14.
Li, Weiqing, Yiming Li, Bangbao Tao, et al.. (2010). MicroRNA-328 may contribute to chemoresistance in glioblastoma cancer stem cells by targeting ABCG2. Medical Science Monitor. 16(10). 3 indexed citations
15.
Ma, Xiaomei, et al.. (2010). An Unusual Case of Pigmented Villonodular Synovitis 14 Years After Total Hip Arthroplasty. The Journal of Arthroplasty. 26(2). 339.e5–339.e6. 6 indexed citations
16.
Sun, Dazhi, Jin He, Ye Lu, et al.. (2010). Tumor interstitial fluid and postoperative recurrence of tumors: An experimental study for verifying hypothesis of “tumor-phlegm microenvironment”. Chinese Journal of Integrative Medicine. 16(5). 435–441. 7 indexed citations
17.
Li, Yiming, Weiqing Li, Yongji Yang, et al.. (2009). MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Research. 1286. 13–18. 163 indexed citations
18.
Liu, Bing, et al.. (2008). Gene expression profiles of nasal polyps associated with allergic rhinitis. American Journal of Otolaryngology. 30(1). 24–32. 15 indexed citations
19.
Yan, Jun, Yanlin Yu, Nan Wang, et al.. (2004). LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene. 23(10). 1939–1949. 52 indexed citations
20.
Hou, Jian, et al.. (2004). IgE Myeloma: the First Report of Chinese Case and a Review ofthe Literature. The Chinese-German Journal of Clinical Oncology. 3(3). 189–191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026